OA05.01 Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy
暂无分享,去创建一个
P. Jänne | E. Schmidt | S. Ramalingam | M. Hellmann | M. Opyrchal | F. Wang | L. Raez | P. Ordentlich | D. Gabrilovich | S. Sankoh | M. Meyers | S. Brouwer | Navid Hafez | P. Ordentlich | S. Sankoh